Summary
A clinical trial is a research study, comprising human volunteers, to test the effectiveness of a new drug. In other words, clinical trials are carried out to find out if proposed treatments work on human beings. A clinical trial for a specific drug takes nearly 9 to 10 years to reach the completion stage.The global clinical trials market is expected to be worth USD16 billion by 2008, up from USD10 billion in 2005 and is growing at 15-18%. Clinical research industry in India touched USD140 million in 2006, up from USD70-80 million in 2001-02 and has been estimated to touch USD200 million by 2007 and USD500-600 m by 2010.
A clinical trial is a long-drawn out process, globally costing anywhere between USD350 and USD500 million. Not surprisingly, a significant share (30%) of clinical trials is now outsourced to Contract Research Organisations (CROs).At a given time, over 3,500 drugs are under development and about 4,000 clinical trial projects are in progress for new drug applications.The report presents Global and indian scenario for clinical trials market in terms of recent trends,major diseases,Pre-clinical trails,regulatory developments etc.
The report covers market scenario in terms of R&D expenditure,drug withdrawals,research on drug price controls etc. The Report profiles listed and unlisted major players with Introduction,Clinical trails expertise,regulatory approvals & recognitions,Collaborations,Financial details etc.Clinical trails report presents information on technology aspects in the industry such as drug design,biochemistry of drugs etc.clinical trails report has highlighted the major growth drivers in the industry along with critical success factors.
It provides information on the regulatory issues in india.clinical trails report presents the information on the issues & challenges in the industry.At the end It presents the future outlook of the clinical trails industry .
|
